| | | | | |
VRRM Verra Mobility Corporation Class A Common Stock | €3,6183 | -2,13% | €572,26M | €2,19M | |
| €5,9312 | +1,05% | €570,94M | €288,41K | |
ACP abrdn Income Credit Strategies Fund | €4,5908 | +0,19% | €570,51M | €328,02K | |
CCOI Cogent Communications Holdings, Inc. | €11,0301 | -0,40% | €569,91M | €573,26K | |
BBOT BridgeBio Oncology Therapeutics, Inc. Common Stock | €7,2892 | -8,47% | €569,17M | €313,45K | |
TRTX TPG RE Finance Trust, Inc. Common Stock | €7,4644 | +1,31% | €568,92M | €626,39K | |
VINP Vinci Compass Investments Ltd. Class A Common Shares | €8,8749 | +2,32% | €568,82M | €19,42K | |
CNNE Cannae Holdings, Inc. Common Stock | €12,7823 | +1,25% | €566,66M | €234,62K | |
| €13,5533 | +0,32% | €565,70M | €210,81K | |
DRUG Bright Minds Biosciences Inc. Common Stock | €68,2350 | -0,40% | €565,55M | €273,09K | |
ANL Adlai Nortye Ltd. American Depositary Shares | €8,7522 | -6,46% | €564,19M | €99,78K | |
EVH Evolent Health, Inc Class A Common Stock | €5,1427 | +4,26% | €562,69M | €1,11M | |
SGP SpyGlass Pharma, Inc. Common Stock | €19,8261 | +12,76% | €560,92M | €138,14K | |
DMII Drugs Made In America Acquisition II Corp. Ordinary Shares | €8,8486 | +0,00% | €559,74M | €1,12K | |
PDT John Hancock Premium Dividend Fund | €11,5120 | +0,84% | €557,59M | €123,92K | |
